A nurse is discussing the pathophysiology of irritable bowel syndrome (IBS) with a client. Which of the following factors should the nurse include as a contributor to the development of IBS?

Brief Introduction: Irritable bowel syndrome (IBS) is a functional disorder characterized by visceral hypersensitivity and altered gastrointestinal motility without structural defects. Pathophysiology involves a complex brain-gut axis disruption where psychosocial stressors and neuroendocrine signaling trigger abdominal pain, bloating, and erratic bowel patterns involving diarrhea or constipation. Rationale: A. IBS is classically defined by the absence of visible structural damage or macroscopic inflammation during endoscopic evaluation. Unlike inflammatory bowel disease, the mucosal integrity remains intact upon biopsy and visual inspection. The symptoms arise from functional disturbances rather than physical erosion of the intestinal lining. B. Prostaglandins are primary mediators of inflammation and uterine contractions, but they are not the central driver of idiopathic dysmotility in IBS. Some medications act on prostanoid receptors; however, the condition is more strongly associated with serotonin signaling and irregular smooth muscle activity. Overproduction is not the primary etiological mechanism. C. Clostridium difficile, a gram-positive, spore-forming anaerobe is the causative agent of pseudomembranous colitis following antibiotic therapy. Although post-infectious IBS can occur after various enteritis events, Clostridium difficile is a specific pathogen causing acute infectious diarrhea. It is not the primary cause of chronic irritable bowel syndrome. D. The bidirectional communication between the enteric nervous system and the central nervous system is frequently dysregulated in this disorder. This neuro-axial disruption leads to an exaggerated perceptual response to normal intestinal distention and gas. Modulation of these neural pathways is a cornerstone of effective clinical management.